"[We've] heard that people
who had trouble getting their refill at first are now able to, and we're
hopeful that is because of the actions we have seen drug manufacturers,
government, state pharmacy boards and other stakeholders take."
— Mike Donnelly, a spokesperson with the Lupus Foundation of
America, spoke with AIS’s RADAR
on Drug Benefits about drug shortages payers, PBMs and stakeholders
have had to address as a result of the COVID-19 pandemic.
No comments:
Post a Comment